Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:3192 |
| Name | neurilemmoma |
| Definition | A neuroma that is characterized as a benign nerve sheath tumor that is composed of Schwann cells. |
| Source | DiseaseOntology.org |
| Alt Ids | DOID:955 |
| Path | disease disease of cellular proliferation benign neoplasm organ system benign neoplasm nervous system benign neoplasm neuroma neurilemmoma |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03095248 | Phase II | Selumetinib | Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (SEL-TH-1601) | Terminated | USA | 0 |
| NCT04283669 | Phase II | Crizotinib | Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NF110) | Completed | USA | 0 |
| NCT04374305 | Phase II | Brigatinib | Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) (INTUITT-NF2) | Active, not recruiting | USA | 0 |